Review Of ‘Breathtakingly Broad’ Cancer Treatment Patent Requested

(October 5, 2018, 12:58 PM EDT) -- ALEXANDRIA, Va. — A patent issued in January to the University of Chicago covers “nearly limitless scope,” a microbiome research and development company asserts in an Oct. 2 petition for post-grant review (PGR) by the Patent Trial and Appeal Board (Genome & Company v. University of Chicago, PGR2019-00002, PTAB)....

Attached Documents

Related Sections